Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection

Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update

(2020)   HEPATOLOGY RESEARCH

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

(2020) Elizabeth C. Verna et al.   JOURNAL OF HEPATOLOGY

Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volume

(2020) Taijiro Wake et al.   PLoS One

Liver Transplantation in Japan: Registry by the Japanese Liver Transplantation Society

(2019) Koji Umeshita et al.   HEPATOLOGY RESEARCH

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan

(2019) Hidenori Toyoda et al.   Open Forum Infectious Diseases

Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection

(2019) Elliot B. Tapper et al.   Clinical Gastroenterology and Hepatology

Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus

(2019) Shohei Tsuji et al.   HEPATOLOGY RESEARCH

OUP accepted manuscript

(2018)   CLINICAL INFECTIOUS DISEASES

EASL Recommendations on Treatment of Hepatitis C 2018

(2018) Jean-Michel Pawlotsky et al.   JOURNAL OF HEPATOLOGY

Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C

(2018) Kei Morio et al.   JOURNAL OF MEDICAL VIROLOGY

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

(2018) Tetsuo Takehara et al.   JOURNAL OF GASTROENTEROLOGY

Efficacy of direct-acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study

(2018) Norio Itokawa et al.   HEPATOLOGY RESEARCH

No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity

(2018) Takuya Hirosawa et al.   INTERNAL MEDICINE

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

(2017) Pierre Nahon et al.   GASTROENTEROLOGY

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry

(2017) Carlos Fernández Carrillo et al.   HEPATOLOGY

Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension

(2017) N. Afdhal et al.   JOURNAL OF VIRAL HEPATITIS

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

(2016) Michael Manns et al.   LANCET INFECTIOUS DISEASES

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

(2015) Michael Charlton et al.   GASTROENTEROLOGY

Management of direct-acting antiviral agent failures

(2015) Maria Buti et al.   JOURNAL OF HEPATOLOGY

Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy

(2015) Saeed H. Al Marzooqi et al.   LIVER INTERNATIONAL

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

(2015) Michael P. Curry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Natural history of hepatitis C

(2014) Rachel H. Westbrook et al.   JOURNAL OF HEPATOLOGY

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET